Yearly Archives: 2022

The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol [...]

The post November 2022 Price Concessions 1st Update appeared first on PSNC Website.

The Chancellor of the Exchequer, Jeremy Hunt, has today (17th November) given his Autumn Statement, setting out Government spending plans. The Statement promises that the NHS budget will be increased in each of the next two years by £3.3bn, going some way towards meeting the request of NHS CEO Amanda Pritchard. But the Chancellor made [...]

The post Autumn Statement: PSNC calls for investment in pharmacies appeared first on PSNC Website.

On Tuesday 15th November PSNC hosted a parliamentary drop-in event for MPs and peers. The event lasted for two hours, during which MPs had the opportunity to drop-in and have their blood pressure measured by pharmacists with experience of working on the front-line and were briefed on the urgent need for action to address the [...]

The post PSNC hosts well attended parliamentary event appeared first on PSNC Website.

In response to a significant ongoing disruption to the supply of Estraderm MX® 50mcg and 75mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 15 November 2022, SSP037 and SSP038 provides for the following: SSP037 – for every Estraderm MX® 50mcg  patch originally prescribed, one [...]

The post Two SSPs issued for Estraderm® MX 50mcg and 75mcg patches appeared first on PSNC Website.

Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (22)A/47 Date issued: 16 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 300 mg prolonged-release tablets, PL 01883/0363 Batch Number Expiry [...]

The post MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.